# Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

> **NCT06178822** · — · RECRUITING · sponsor: **Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)** · enrollment: 3300 (estimated)

## Conditions studied

- Sepsis
- Septic Shock
- Sepsis, Severe
- Infections
- Infection Viral
- Infection, Bacterial
- Infections, Respiratory

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06178822
- **Lead sponsor:** Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-25
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 3300 (ESTIMATED)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06178822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06178822, "Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06178822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*